...
首页> 外文期刊>Hematological oncology >The new World Health Organization classification of lymphomas: the past, the present and the future.
【24h】

The new World Health Organization classification of lymphomas: the past, the present and the future.

机译:世界卫生组织对淋巴瘤的新分类:过去,现在和未来。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The REAL Classification of lymphomas, proposed in 1994, represents a new paradigm in lymphoma classification, consisting of a list of biologic entities defined by clinicopathologic and immunogenetic features. The non-Hodgkin's lymphomas comprise precursor lymphoblastic and mature cell neoplasms of B, T or putative natural killer cell lineage. An individual entity can exhibit a range of morphologic appearances and a range of clinical behavior. The categories in Hodgkin's lymphomas are identical to the widely used Rye classification except for the additional of a new category termed 'lymphocyte-rich classical Hodgkin's lymphoma'. The REAL classification has been validated by a major multi-institutional study involving 1378 cases (The Non-Hodgkin's Lymphoma Classification Project), showing that it is both reproducible and clinically relevant. The new World Health Organization classification of hematopoietic and lymphoid tumors, to be published in 2001, is a joint project of the Society for Hematopathology and European Association of Hematopathologists, under the auspices of the World Health Organization. This classification includes not only lymphoid neoplasms, but also myeloid, histiocytic and mast cell neoplasms. The lymphoma component of the classification is merely an update of the REAL classification, with minor changes necessitated by new information that has become available since its proposal. A conceptual grouping of the non-Hodgkin's lymphomas into four categories (indolent, aggressive, highly aggressive, and localized indolent) is also presented in this review. The next major impetus influencing the approach to lymphoma classification will no doubt be molecular genetics, in particular DNA microarrays, which will yield an enormous amount of new data that will aid in the understanding of lymphomas. Copyright 2001 John Wiley & Sons, Ltd.
机译:1994年提出的REAL淋巴瘤分类代表了淋巴瘤分类的新范式,由临床病理和免疫遗传学特征定义的一系列生物学实体组成。非霍奇金淋巴瘤包括B,T或假定的自然杀伤细胞谱系的前体淋巴母细胞和成熟细胞肿瘤。单个实体可以表现出一系列的形态学外观和一系列的临床行为。霍奇金淋巴瘤的类别与广泛使用的Rye分类相同,只是增加了一个新类别,即“富含淋巴细胞的经典霍奇金淋巴瘤”。 REAL分类已通过一项涉及1378例病例的大型多机构研究的验证(非霍奇金淋巴瘤分类项目),表明其具有可重复性和临床意义。世界卫生组织在世界卫生组织的主持下,于2001年公布了新的世界卫生组织对造血和淋巴瘤的分类,这是血液病理学会和欧洲血液病理学家协会的一项联合项目。该分类不仅包括淋巴样肿瘤,还包括髓样,组织细胞和肥大细胞肿瘤。该分类的淋巴瘤成分仅是REAL分类的更新,自提议以来,新信息就需要进行细微的更改。本文还将非霍奇金淋巴瘤的概念性分组分为四类(惰性,侵袭性,高度侵袭性和局限性惰性)。毫无疑问,影响淋巴瘤分类方法的下一个主要推动力将是分子遗传学,尤其是DNA芯片,它将产生大量有助于理解淋巴瘤的新数据。版权所有2001 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号